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Abstract
BACKGROUND: Despite the advances in medical and surgical care have improved the survival rates of children 
with congenital heart disease (CHD), they still remain risky for nutritional, cognitive problems, and quality of life. 
Those impacts vary according to the severity of heart lesions and still manifested years after surgery. 
AIM: The objective of this study was to compare growth, development, and quality of life between cyanotic and 
acyanotic CHD.
METHODS:  The study was performed on 52 patients aged 24–69 months old from June to January 2018 in Sanglah 
Pediatric Cardiology clinic used WHO Anthro software, The Mullen Scales of Early Learning and PedsQL Cardiac 
module. 
RESULTS: We found significant different proportion of underweight 11.5% in acyanotic children, 42.3% in cyanotic 
by weight/age z-score <−2SD (p = 0.033). Height/ age z-score <−3SD 38.5% in cyanotic versus 11.5% in acyanotic 
(p = 0.025). The cyanotic showed a significant difference in cognitive function, presented by early learning composite 
score (p = 0.044) particularly in gross motor (p = 0.034) and receptive language (0.047). Quality of life differs 
significantly between both groups in heart problem and therapy (p = 0.042), treatment anxiety (p = 0.016), cognitive 
problems (p = 0.038), and communication (p = 0.022). 
CONCLUSION: Development, growth problems, and lower quality of life are common in cyanotic children, thus 
highlight the need for longitudinal surveillance.
Edited by: Sinisa Stojanoski
Citation: Maya S, Gunawijaya E, Yantie NPVK, 
Windiani IGAT. Growth, Development, and Quality of Life 
in Children with Congenital Heart Disease. Open Access 
Maced J Med Sci. 2020 Aug 20; 8(B):613-618. 
https://doi.org/10.3889/oamjms.2020.4047
Keywords: Congenital heart disease; Cognitive; 
Quality of life
*Correspondence: Sri Maya, Department of Child Health, 
Sondosia General Hospital, Bima, West Nusa Tenggara, 
Indonesia. E-mail: srimaya99@yahoo.com
Received: 11-Nov-2019
Revised: 18-Jul-2020
Accepted: 21-Jul-2020
Copyright: © 2020 Sri Maya, Eka Gunawijaya, 
N. P. Veny Kartika Yantie, I. G. A. Trisna Windiani
Funding: This research did not receive any financial 
support
Competing Interests: The authors have declared that no 
competing interest exists
Open Access: This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 4.0)
Introduction
Congenital heart disease (CHD), the most 
common cause of major congenital anomalies, 
representing global health problems in pediatric patients 
[1], [2], [3], [4] with estimated prevalence is 8 per 1000 
live births [1]. Despite the advances of medical and 
surgical care, the increase in survival rates of children 
with heart disease into adulthood increase [2], several 
investigators have demonstrated children with CHD 
remain at risk for nutritional [1] and cognitive problems 
[5], [6], [7], [8], [9] which rely on the complexity of the 
heart lesion. The cognitive disorders include areas 
of intelligence, academic achievements, languages, 
visual construction perceptions, attention, executive 
functioning, fine motor skills, gross motor skills, and 
psychosocial maladjustment [6], [7]. The impacts of 
cognitive outcomes for these children vary widely, 
according to the severity of heart lesions [5] and still 
being observed many years after successful surgery, 
manifested as learning or behavioral difficulties, which 
implies that they are not transient in nature [6].
Despite most of the CHD children have normal 
birth weight, they tend to develop malnutrition within the 
first months of life [10], [11]. Decreased energy intake, 
tissue hypoxia, cardiac acidosis, peripheral acidosis, 
intestinal malabsorption, increased energy requirement, 
and attribute infection increase metabolism rate, 
which ends to growth impairment [1], [3], [10], [12]. 
Cyanotic heart defect children commonly demonstrate 
markedly poor growth compared with acynotic defect 
children [10], [13]. As these children reach adulthood 
those morbidities can limit educational achievements, 
employability, insurability, and can particularly affect the 
child’s overall health-related quality of life [7]. As shown 
by several studies children with cyanotic heart defect 
have a lower score in quality of life compared with 
healthy peers in the same age group [14]. In effort to 
improve the outcome, we aimed to study the nutritional 
status, cognitive function, and quality of life in children 
with cyanotic and acyanotic CHD.
Materials and Methods
This cross-sectional study was conducted from 
June 2017 to January 2018, Bali, after obtaining clearance 
from the institutional ethics committees of Udayana 
university with protocol study number 2017.02.1.0542. 
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This study consecutively recruited congenital heart 
defect children aged 24–69 months old (cyanotic and 
acyanotic) in Pediatric Cardiology outpatient clinic, with 
consideration of the instrument we use and cooperation 
from the child. As we know, 24 months is the starting 
age to assess the quality of life using PedsQL Cardiac 
module. Meanwhile, for neurocognitive evaluation using 
The Mullen Scales of Early Learning (AGS edition) were 
limited from birth to 69 months old. The required sample 
size was calculated based on the study by Nasiruzzaman 
et al. [3] and Rachmawati et al. [4] using power 95%, 
alpha 5% (two-tail), estimated proportion difference 
(P1-P2) 40%, and gross motor as the most frequent 
cognitive problem (which affected 60% of their sample; 15 
from 28 acyanotic; and 15 from 22 acyanotic) [3]; we got 
26 children per group from unpaired categorized analytic 
formula. Meanwhile, the proportion of malnutrition based 
on the WHO criteria was 19 from in 28 acyanotic [9], with 
P2 0.67, we got 13 subjects per group.
The comparison quality of life from 17 cyanotic 
children with 37 acyanotic children showed that quality 
of life-based on parental report was significant lower in 
cyanotic group in the following segments including heart 
problem and therapy (53.3 ± 9.26 vs. 71.4 ± 7.75; p = 
0.007), physical appearance (67.5 ± 20.57 vs. 90.2 ± 
4.89; p = 0.033), treatment anxiety (57.3 ± 11.34 vs. 
83.6 ± 14.28; p = 0.001), and cognitive problem (53.3 
± 5.16 vs. 78.3 ± 4.85; p = 0.001) [14]. Based on that, 
the composite of standard deviation using the formula 
for unpaired analytic categories and numeric we got the 
biggest sample size was 21 children per group. From 
the above calculation, we concluded 26 children per 
group as the biggest sample size for each group.
Children were eligible for inclusion if they 
presented with symptoms and signs suggestive of 
CHD, which had been confirmed by echocardiographic 
examination, parents both mentally and educationally 
capable of answering the questionnaire and agree to 
participate by signing the informed consent after been 
explained the purpose of the study. Patient was excluded 
from the study if they have clinically genetic syndrome 
or disorders (Turner, Down, VACTERL association, 
microcephaly, deafness, blindness), neurologic disorder 
(cerebral palsy, epilepsy), hematologic or oncology 
problem (ITP, thalassemia, retinoblastoma, and 
leukemia), or history of psychiatric problem. Psychiatric 
problem was assessed if the patient had medical history 
of being consulted to the psychiatric department or 
consuming psychiatric medication. Full medical history 
as well as complete cardiac examination, including the 
result of echocardiography, catheterization (if one had 
been done), was documented for all children.
Variables definition
Cyanotic heart disease was defined as type of 
CHD that occurs due to structural defect of the heart 
(right to left shunting, and malposition of great artery) 
or any condition which increases pulmonary vascular 
resistance that causes mixture of oxygenated and 
unoxygenated blood entering the systemic circulation 
with oxygen saturation <85%, for example, tetralogy of 
Fallot, hipoplastic left heart syndrome, transposition of 
great artery, tricuspid atresia, pulmonary atresia, and 
atrioventricular septal defect.
Acyanotic heart disease was defined as type 
of CHD that occurs due to structural defect of the heart 
that causes left to right shunting, with normal level of 
oxyhemoglobin saturation in systemic circulation, for 
example, ventricular septal defect, atrial septal defect, 
and patent ductus arteriosus.
Economy class was defined from monthly 
family income such as money received periodically 
from commerce, employment, and investments based 
on Bali Governor decrits no 67/2016 with minimum 
wages in Denpasar was Rp.2.173.000/month. 
Anthropometric measurements included weight 
(kilogram) and height (centimeter) were performed 
according to standard WHO procedures. Nutritional 
status was interpreted from Waterlow, the percentage 
ratio of observed weight, and expected weight from 
observed height.
In the purpose of assessing child’s 
development status in cognitive and motor ability, we 
used The Mullen scales of early learning (AGS edition), 
which consisted of gross motor, visual reception, fine 
motor, expressive language, and receptive language 
from birth to 68 months with completion time: 15 min 
(1 year); 25–35 min (3 years); and 40–60 min (5 years).
The children’s quality of life were assessed 
using the PedsQL Cardiac module, which was specific 
to toddlers (2–4 years of age) and young child (5–7 
years of age) with heart disease by parents’ response. 
The higher the score, the better the child’s quality of life.
Those data, including anthropometric, 
development, and quality of life, were compared between 
cyanotic and acyanotic children. Quantitative data were 
presented in frequency and percentage. The Shapiro–Wilk 
test was used to analyze the data distribution if p > 0.05, 
then its normally distributed and presented as mean and 
standard deviation (weight in cyanotic, height cyanotic, 
and acyanotic group). Data with normal distribution were 
presented as median and percentile, such as age in 
cyanotic and acyanotic, and weight in acyanotic group. 
Categorical data including nutritional status, body mass 
index/age, gross motor, fine motor, receptive language, 
and early learning composite were analyzed using Chi-
square (weight/age z-score [WAZ], and height/age 
z-score [HAZ]) or Mann–Whitney. Unpaired t-test was 
used to compare continuous variable with a normal 
distribution (cognitive problems) and Mann–Whitney for 
abnormal distributed data (heart problem and therapy, 
treatment, perceived physical appearance, treatment 
anxiety, and communication). The significance level was 
set at p < 0.05.
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Results
Demographic and anthropometric 
characteristics of the samples are shown in Table 1. 
The median age was 34.0 months for cyanotic CHD 
children and 28.5 months for acyanotic CHD children, 
most of them were dominated by male patients. The 
majority of patients (both cyanotic and acyanotic) 
were from middle economic class with monthly income 
around Rp.2.173.000–6.519.000, and their healthcare 
were covered by government health insurance. No 
significant difference in baseline characteristics was 
seen in both groups.
Table 1: Demographic and anthropometric characteristic
Demographic characteristic Cyanotic CHD 
(n=26)
Acyanotic CHD 
(n=26)
Age, months, median (p10–90) 34/24–65.6* 26/24–48*
Gender (males/females) 12/14 7/19
Family income, n (%)
Lower class 5 (19.2%) 3 (11.5%)
Middle class 17 (65.3%) 22 (84.6%)
Upper class 4 (15.3%) 1 (3.8%)
Anthropometric characteristic, mean (SD)
Weight, kg 11.75 (2.92)** 11 (8–15.3)*
Height, cm 89.76 (11.98)** 87.26 (9.55)**
CHD: Congenital heart disease.
The cyanotic group was dominated by 
Tetralogy of Fallot; meanwhile, the acyanotic group 
was dominated by ventricle septal defect, as shown in 
Table 2.
Table 2: Distribution of heart disease among the patients
Congenital heart disease Frequency n (%)
Acyanotic
PDA 6 (23)
ASD 3 (11.5)
VSD 13 (50)
COA + PDA 1 (3.8)
PS + ASD-II 3 (11.5)
Cyanotic 
TOF 13 (50)
TA 1 (3.8)
DORV 4 (15.4)
ECD 3 (11.4)
RV hypoplasia 1 (3.8)
Pulmonary atresia 1 (3.8)
PTA 3 (11.5)
ASD: Atrial septal defect, ECD: Endocardial cushion defect, COA: Coarctation of the aorta, DORV: Double 
outlet right ventricle, PDA: Patent ductus arteriosus, PS: Pulmonary stenosis, TOF: Tetralogy of Fallot, 
PTA: Persistent truncus arteriosus, RV: Right ventricle, VSD: Ventricle septal defect, SADC: Sub arterial 
double committed, TA: Tricuspid atresia, TR: Tricuspid regurgitation, PR: Pulmonary regurgitation.
In Table 3, we found a significant difference 
in proportion of underweight in CHD children (p = 
0.008). In cyanotic, the proportion of underweight 
(WAZ <−2SD) was 43.3%, which was higher than 
acyanotic that only 10%. A significant difference was 
also found in the height/age (p = 0.024) in which the 
cyanotic group showed normal height only in 23.3%, 
compared with acyanotic, which showed 56.7%. 
Meanwhile, the proportion of severely stunted was 
higher in cyanotic (23.3%) rather than acyanotic 
(13.3%).
The cognitive scores profile of cyanotic and 
acyanotic CHD children are shown in Table 4. The 
Table 3: Comparison of anthropometric profile
Anthropomrtric variables Cyanotic CHD (n=26) Acyanotic CHD (n=26) p
Nutritional status+
Overweight 3 (11.5) 5 (19.2) 0.149
Normal 3 (11.5) 7 (26.9)
Mild malnutrition 12 (46.2) 9 (34.6)
Moderate malnutrition 7 (26.9) 3 (11.5)
Severe malnutrition 1 (3.8) 2 (7.7)
WAZ
Normal 8 (30.8) 17 (65.4) 0.033
Underweight 11 (42.3) 3 (11.5)
Severe underweight 7 (26.9) 6 (23.1)
HAZ
Normal 5 (19.2) 13 (50.0) 0.025
Stunted 11 (42.3) 10 (38.5)
Severe stunted 10 (38.5) 3 (11.5)
BMI/age+
Obese 3 (11.5) 2 (7.7) 0.149
Risky for overweight 0 (0.0) 2 (7.7)
Normal weight 17 (65.4) 13 (50.0)
Wasted 4 (15.4) 5 (19.2)
Severe wasted 2 (7.7) 4 (15.4)
+Mann–Whitney, WAZ: Weight for age z-score, HAZ: Height for age z-score, BMI: Body mass index, 
CHD: Congenital heart disease.
cyanotic CHD children significantly showed lower scored 
than acyanotic children in gross motor (p = 0.034) and 
in receptive language (p = 0.048) which had effect on 
early learning composite score (p = 0.014).
Table 4: Comparison of cognitive function by Mullen
Cognitive function Cyanotic CHD (n=26) Acyanotic CHD (n=26) p
Gross motor+
NA 15 (57.7) 9 (34.6) 0.034
Very low 8 (30.8) 8 (30.8)
Below average 2 (7.7) 2 (7.7)
Average 1 (3.8) 7 (26.9)
Visual reception
Very low 12 (46.2) 10 (38.5) 0.627
Below average 9 (34.6) 8 (30.8)
Average 5 (19.2) 8 (30.8)
Fine motor+
Very low 13 (50.0) 14 (53.8) 0.833
Below average 9 (34.6) 5 (19.2)
Average 4 (15.4) 6 (23.1)
Very high 0 (0.0) 1 (3.8)
Receptive language+
Very low 10 (38.5) 6 (23.1) 0.047
Below average 9 (34.6) 4 (15.4)
Average 6 (23.1) 16 (61.5)
Above average 1 (3.8) 0 (0)
Expressive language
Very low 13 (50.0) 7 (26.9) 0.231
Below average 6 (23.1) 9 (34.6)
Average 7 (26.9) 10 (38.5)
Early learning composite+
Very low 16 (61.5) 9 (34.6) 0.044
Below average 3 (11.5) 5 (19.2)
Average 7 (26.9) 9 (34.6)
Above average 0 (0.0) 3 (11.5)
+Mann–Whitney, CHD: Congenital heart disease
The quality of life assessment from parent’s 
report in cyanotic and acyanotic CHD children is 
shown in Table 5. In general, the cyanotic children 
showed lower scores in all the trajectories than children 
with congenital acyanotic heart disease. Significant 
differences were found in heart problem and therapy 
(p = 0.042), treatment anxiety (p = 0.016), cognitive 
problems (p = 0.038), and communication (p = 0.022).
Table 5: Quality of life comparison
Variables Cyanotic CHD (n=26) Acyanotic CHD  
(n=26)
p
Heart problem and therapy 48.46 (17.55)** 62.49 (31.09–92.85)* 0.042
Treatment 100 (25–100)* 100 (44.99–100)* 1.000
Perceived physical 
appearance
100 (89.16–100)* 100 (78.32–100)* 0.708
Treatment anxiety 31.25 (25–81.25)* 75 (25–100)* 0.016
Cognitive problems 46.40 (21.31)** 60.76 (26.63)** 0.038
Communication 75 (25–100)* 100 (42.5–100)* 0.022
* median, p10–90 (data not distributed normally), **mean, SD (data distributed normally), CHD: Congenital 
heart disease.
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Discussion
Consistent with the previous study on the 
developmental outcome of children with CHD, our study 
also found that nutritional problem [3], [10], [15], cognitive 
delay [3], [5], [9], and lower quality of life [8], [14] are 
common problems in CHD children [10]. In nutritional 
assessment, both groups showed the same proportion 
of severely underweight 50.0%. The cyanotic group was 
dominated significantly by underweight (WAZ <-2) 42.3%, 
which differ from the acyanotic group; the proportion of 
underweight was 15.4%, while it was more dominated 
by normal weight (65.4%). Severe stunted proportion 
was higher in cyanotic group 38.5% compared with 
acyanotic only 11.5%. Most of the acyanotic group 
was found had normal height (50%) based on HAZ, in 
comparison to cyanotic group, which was dominated 
by stunted children (42.3%). Cyanotic patients were 
affected in growth, depending on the severity of tissue 
hypoxemia and the degree of physiological adaptation. 
Acyanotic lesions, affect weight more than height. In 
other words, cyanotic lesions were related to chronic 
malnutrition, whereas acyanotic lesions were related to 
acute malnutrition [15].
Our study is in accordance with study in 
India, which showed the majority of the CHD children 
were malnourished, and weight was found to be more 
affected than height in both cyanotic and acyanotic 
groups. Both height and weight were affected much 
more in the cyanotic group when compared to 
acyanotic group, despite not significant statistically by 
height category [12]. It also appropriates with a study 
in Cairo which found that malnutrition, stunting, and 
wasting proportion were significantly higher among 
cyanotics (62.8%, 74.4%, and 25.6%) compared with 
acyanotics (49.5%, 63.3%, and 18.3%) [12]. In addition, 
cyanotic heart defect was known to have a correlation 
with the decrement of insulin growth factor-1 level 
(r = 0.402, p < 0.05) [14], which is in agreement with 
Eren et al. who stated chronic hypoxia had a negative 
effect on nutrition and growth hormone, by decreasing 
insulin growth factor-1 (somatomedin) level that is 
produced in the liver and regulated by the binding of 
growth hormone to growth hormone receptors. These 
findings indicated that chronic hypoxemia might serve 
as the underlying cause by decreasing the production 
of insulin growth factor-1 which induced growth failure 
in patients with cyanotic CHD [11], [16], [17].
Normal fetal brain growth and development rely 
on adequate delivery of oxygen and substrate, which 
is influenced by the anatomic structure of the heart 
and myocardial function [9]. CHD fetal has delayed 
brain growth since the third trimester, characterized 
by a decrement of N-acetylaspartate/Choline ratio 
(Naa/Cho) and Choline/Creatinine ratio (Cho/Cr), and 
increment of Myoinositol/Choline (Ino/Cho) and lactate 
[18]. Thus underlies the worse neurocognitive outcomes 
[9] in children with cyanotic heart defects due to less 
mature macro and micro structural brain development 
with lower total brain volume as proven by Rollins et al., 
that CHD children have reduction of total brain volume 
at 1 year of age driven by differences in cerebral white 
matter which correlates with language impairment [18]. 
In our study, receptive language impairment was more 
significant in cyanotic group compared with acyanotic, 
which can be caused by the reduction of total brain 
volume (p = 0.047).
In addition, the prolonged period of hypoxics 
cerebral vascular tone in CHD tends to normalize, with 
downregulation of neuronal and glial metabolism that 
results in reduced cerebral VO2 leads to periventricular 
leukomalacia, characterized by focal necrosis in the 
periventricular white matter [19], [20], [21]. Those 
alterations of white matter will disturb volumetric growth, 
gyrification of the cortical gray matter, and impair 
myelination which linked to worse cognition, motor and 
behavioral functioning, as well [22], [23].
Recently, a systematic review stated that brain 
metabolism and microstructural development also 
played role in delayed cerebral development, which was 
significantly lower than neonates without congenital 
heart defect and corresponded to a delay of 4 weeks in 
structural brain sulcation [23]s.
Our study showed the proportion of 
underweight was significantly higher in cyanotic 
group, which would increase morbidity and mortality, 
as indicated by frequent hospitalization, poor surgical 
outcomes, persistent impairment of somatic growth, 
and increased death. The underweight can be caused 
by feeding problems such as inadequate nutritional 
intake or absorption, feeding difficulty, excessive energy 
expenditure, frequent respiratory infections, limitation 
of growth potential, and genetic syndromes [15]. 
The feeding difficulty in CHD infants can be linked 
to oropharyngeal dysphagia [24]. Moreover, these 
feeding and language problems also can be linked 
to the immaturity of brain development proven by the 
incomplete closure of the cerebral opercula, which is 
the sensory-motor cortical representation of buccal, 
glottis, and esophageal structures, as well as receptive 
and expressive language [20].
Besides nutrition, in cognitive trajectory 
evaluated by Mullen showed that cyanotic group had 
significant impairment in gross motor and receptive 
language than acyanotic group. It showed agreement 
with a study in Bangladesh in which about 32% had 
cognitive impairment, 44% children had speech 
delay, with gross motor and fine motor delay as the 
main developmental problems [25]. Besides brain 
impairment, the development of motor skills in 
children (infants until school-age) also takes place 
as a resultant of activity and interaction between 
person and environment. Children influence their 
environment in an active way and adapt their behavior 
to the environment. Movement serves as a catalyst 
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in a child’s development. In this way, high level of 
movement ensures the advancement of the child’s 
physical development, especially the locomotor 
system, which, through movement, gains the impulses 
needed for normal development [26]. Interestingly, we 
also found parents focused on the treatment and tend to 
restrict their child physical activity. We assumed it was 
caused by lack of adequate information to caregiver 
or parents, who limit the child’s motoric stimulation 
that possibly causes development delay by restriction 
of physical activity and sheltered upbringing by main 
caregivers, who are generally more protective. Majority 
of parents who have children with CHD were reported 
to have a higher stress level compared with the normal 
population that makes them difficult to set limit and 
control for their children. They tend to assimilate their 
parenting style in accordance with the child’s need that 
leads to overprotective behavior. Finally, it will limit the 
children interaction with their peers, not least regarding 
physical activity, which might influence the child’s social 
competence and motor development [26].
Despite the measures taken to treat, these 
children may experience maladjustment in physical 
activities, social relationships, academic performances, 
and emotional, which decrease the quality of life in CHD 
patients. The quality of life assessment from parent’s 
reports in cyanotic significantly lower than acyanotic 
in the following aspect such as heart problems and 
therapy, treatment anxiety, cognitive problems, and 
communication. In our study, the cyanotic showed the 
poor quality of life than acyanotic heart disease children; 
it supposed to be related to the difference in cognitive 
and nutritional status. Therefore, a multidisciplinary 
approach should be applied for early identification of 
those impairments to offer the best opportunity for 
treatment that may allow the child to reach the fullest 
potential in adulthood and minimize the negative impact 
on the quality of life and parents should be more aware 
and responsive to the development and nutrition aspect 
of their child [27].
Conclusion
Cognitive delay, nutritional problems, and 
quality of life are common in cyanotic CHD children.
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